0001493152-23-007923.txt : 20230316 0001493152-23-007923.hdr.sgml : 20230316 20230316163019 ACCESSION NUMBER: 0001493152-23-007923 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20230311 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20230316 DATE AS OF CHANGE: 20230316 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NewHydrogen, Inc. CENTRAL INDEX KEY: 0001371128 STANDARD INDUSTRIAL CLASSIFICATION: UNSUPPORTED PLASTICS FILM & SHEET [3081] IRS NUMBER: 000000000 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-54819 FILM NUMBER: 23739226 BUSINESS ADDRESS: STREET 1: 27936 Lost Canyon Road STREET 2: Suite 202 CITY: Santa Clarita STATE: CA ZIP: 91387 BUSINESS PHONE: 6612510001 MAIL ADDRESS: STREET 1: 27936 Lost Canyon Road STREET 2: Suite 202 CITY: Santa Clarita STATE: CA ZIP: 91387 FORMER COMPANY: FORMER CONFORMED NAME: BioSolar Inc DATE OF NAME CHANGE: 20060801 8-K 1 form8-k.htm
0001371128 false 0001371128 2023-03-11 2023-03-11 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): March 11, 2023

 

NEWHYDROGEN, INC.

(Exact name of registrant as specified in its charter)

 

Nevada   000-54819   20-4754291
(State or other jurisdiction   (Commission   (IRS Employer
of incorporation)   File Number)   Identification No.)

 

27936 Lost Canyon Road, Suite 202, Santa Clarita, CA 91387

(Address of principal executive offices and Zip Code)

 

Registrant’s telephone number, including area code: (661) 251-0001

 

N/A

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Ticker symbol(s)   Name of each exchange on which registered
N/A   N/A   N/A

 

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b2 of the Securities Exchange Act of 1934 (§240.12b2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 
 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

Director Departure

 

On March 11, 2023, Spencer Hall notified NewHydrogen, Inc. (the “Company”) of his decision to resign as a director of the Company effective March 11, 2023. Mr. Hall’s resignation was not the result of any disagreement with the Company or any matter relating to the Company’s operations, policies or practices.

 

Appointment of New Officer and New Director

 

On March 14, 2023, the Company appointed Mr. Steve Hill as the Vice President and a Director of the Company, effective as of March 20, 2023. Mr. Hill is an accomplished sales executive with over 20 years of experience in the biopharmaceutical industry and over 6 years of experience in the real estate industry. From March 2022 to February 2023, Mr. Hill served as a sales associate for Alemann and Associates Realty in Santa Barbara, CA. From October 2016 to February 2023, he served as a managing member of Hill Investments, LLC, a real estate investment and design group during which time Mr. Hill consulted on property development and managed real estate investments. From December 2015 to October 2021, he served as a regional account manager for Relypsa Inc, a biopharmaceutical start-up in Redwood City, CA. Mr. Hill’s experience in the pharmaceutical industry leading up to Relypsa began in 2000 with roles varying from sales to marketing and leadership with AstraZeneca, Organon, Schering-Plough and Daiichi Sankyo. Mr. Hill received a Master of Business Administration degree from IE Business School, a Bachelor of Science in Technology Management degree from Utah Valley University and an Associate of Science in Aviation Science degree from Utah Valley University.

 

The Board of Directors (the “Board”) of the Company has concluded that Mr. Hill is qualified to serve as a director of the Company because of his diverse experience in technology, marketing, and executive management.

 

On March 11, 2023, the Company and Mr. Hill entered into an employment offer letter (the “Employment Offer Agreement”). Pursuant to the terms of the Employment Offer Agreement, Mr. Hill will be entitled to an annual base salary of $250,000. Mr. Hill will also receive 50,000,000 stock options, each to vest over a three-year period and subject to a six-month cliff.

 

There is no arrangement or understanding between Mr. Hill and any other person pursuant to which he was selected as Vice President and a Director of the Company. In addition, there are no familial relationships between Mr. Hill and any director or executive officer of the Company and Mr. Hill is not a party to any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K. Effective upon his appointment as Vice President of the Company, Mr. Hill will be designated as an “officer” as such term is used within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).

 

The foregoing description of the terms of the Employment Offer Agreement does not purport to be complete and is qualified in its entirety by the full text of the Employment Offer Agreement, a copy of which is attached to this Current Report on Form 8-K as Exhibit 10.1 and incorporated herein by reference.

 

Named Executive Officer Base Salary Adjustment

 

On March 14, 2023, the Board approved an increase to the base salary of David Lee, the Company’s Chief Executive Officer, resulting in a base salary of $300,000, effective March 1, 2023.

 

Exhibit No.   Description
     
10.1   Employment Offer Agreement, dated March 11, 2023
104   Cover Page Interactive Data File - The cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  NewHydrogen, Inc.
   
Date: March 16, 2023 /s/ David Lee
  David Lee
  Chief Executive Officer

 

 

 

EX-10.1 2 ex10-1.htm

 

Exhibit 10.1

 

 

March 11, 2023

 

Steven Hill

alpinehills@gmail.com

 

Re: Offer of Employment

 

Dear Steve:

 

On behalf of NewHydrogen, Inc., a Nevada Corporation, (the “Company”), I am pleased to offer you (the “Employee”) employment, under the following terms and conditions. This Offer of Employment shall expire after March 15, 2023, if not fully executed before then.

 

Title: Vice President
   
Report to: CEO
   
Job Description: Responsible for all duties and responsibilities assigned by the Company’s CEO including but not limited to communicating the Company’s value to investors, media, public, and potential partners.
   
Type: Full time (100%)
   
Location: Home office or other approved remote locations.
   
Base Salary: $20,833.33 per month (equivalent to an annualized salary of $250,000), subject to modification from time to time during your employment in accordance with the Company’s practices, policies, or procedures.

 

Stock Option Grant: 50,000,000 shares

 

  3-year vesting with a 6-month cliff
  exercise price: closing market price on the day of the grant
  cashless exercise

 

Medical: The Company will reimburse you for premiums on your private medical insurance plan.
   
Term of Employment: Your employment with the Company is “at-will,” and may be terminated at any time by you or by the Company, for any reason or no reason, upon written notice. Nothing in this letter creates a promise or representation of continued employment for a term or limits the Company’s right and power to terminate your employment at any time.

 

1
 

 

Date of Employment: Effective on March 20, 2023 and upon proper legal documents showing proof of eligibility of employment in the United States as required by Form I-9.
   
Arbitration: Any dispute arising with respect to your employment or the termination of your employment with the Company shall be conclusively settled by final and binding arbitration in accordance with the arbitration procedures described in the attached Employee Confidentiality and Inventions Agreement.
   
Company Policies: From time to time you will be advised of certain Company policies, including such policies as may from time to time be set forth in an employee handbook or similar document. As a condition of your employment, you agree to comply with such policies.
   
Outside Consulting: You agree not to take on other consulting jobs or be an employee of another business without the written consent of the Company.

 

Enclosed are an Employee Confidentiality and Inventions Agreement and a Termination Certificate. Our offer is contingent on your understanding and agreement, as evidenced by your signing below, that: (i) you will execute the Employee Confidentiality and Inventions Agreement as a prerequisite to your employment; (ii) upon your termination, you will execute a Termination Certificate (or document containing similar provisions); (iii) on the Date of Employment, you are not an employee or consultant in any other business.

 

By signing this letter, you acknowledge that the terms described in this letter, together with the enclosed Employee Confidentiality and Inventions Agreement, sets forth the entire understanding between us and supersedes any prior representations or agreements between us, whether written or oral. There are no terms, conditions, representations, warranties or covenants relating to your employment other than those contained herein. No term or provision of this letter may be amended waived, released, discharged or modified except in writing, signed by you and an authorized officer of the Company, except that the Company may, in its sole discretion, adjust your salary, incentive compensation, benefits, job title, location, duties, responsibilities, and reporting relationships.

 

Welcome to the team; we look forward to working with you. Please feel free to contact me with any questions or concerns. Please sign below and email this offer back to david@newhydrogen.com

 

Sincerely,   Offer Accepted:
     
/s/ David Lee   /s/ Steven Hill
David Lee   Steven Hill
President and CEO    

 

NewHydrogen, Inc., 27936 Lost Canyon Road, Suite 202, Santa Clarita, CA 91387

Tel (661) 251-0001 ● Fax (661) 251-0003 ● www.NewHydrogen.com

 

2
 

 

NEWHYDROGEN, INC.

 

EMPLOYEE CONFIDENTIALITY & INVENTIONS AGREEMENT

 

This Agreement is entered by and between NEWHYDROGEN, Inc. (the “Company”) and Steven Hill (“Employee”) effective as of the first date on which the Employee provides services for the Company.

 

In consideration of the promises and mutual covenants herein contained, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, it is mutually covenanted and agreed by and between the parties as follows:

 

1. Confidential Information.

 

(a) Company Information. Employee shall at all times during the term of Employee’s employment with the Company and thereafter, hold in strictest confidence, and not use, except for the benefit of the Company, or disclose to any person, firm or corporation without written authorization of the Company’s management, any Confidential Information of the Company. As used herein, “Confidential Information” means any Company proprietary information, technical data, trade secrets or know-how, including, but not limited to, research, product plans, products, services, investors, business partners, customer lists and customers (including, but not limited to, those of the Company on whom Employee has called or with whom Employee became acquainted during the term of Employee’s employment), markets, technology, developments, inventions, processes, methods of operation, formulas, designs, drawings, engineering, marketing, finances or other business information disclosed to Employee by the Company either directly or indirectly in writing, orally or by drawings or observation of parts or equipment. “Confidential Information” does not include any of the foregoing items which has become publicly known and made generally available through no wrongful act of Employee or of others who were under confidentiality obligations as to the item or items involved or improvements or new versions thereof.

 

(b) Former Employer Information. Employee shall not, during Employee’s employment with the Company, improperly use or disclose any proprietary information or trade secrets of any former or concurrent employer or other person or entity and Employee shall not bring onto the premises of the Company any unpublished document or proprietary information belonging to any such employer, person or entity unless consented to in writing by such employer, person or entity.

 

(c) Third Party Information. Employee shall hold all confidential or proprietary information that the Company has received from any third party to which it is the Company’s obligation to maintain the confidentiality of such information and to use it only for certain limited purposes in the strictest confidence and not to disclose it to any person, firm or corporation or to use it except as necessary in carrying out Employee’s work for the Company consistent with the Company’s agreement with such third party.

 

2. Inventions. Employee hereby represents, warrants and covenants with respect to Prior Inventions or Inventions (each, as defined below), as the case may be, as follows:

 

(a) Inventions Retained and Licensed. Attached hereto, as Exhibit A, is a list describing all inventions, original works of authorship, developments, improvements, and trade secrets which were made by Employee prior to Employee’s employment with the Company (collectively referred to as “Prior Inventions”), which belong to Employee (and not to any prior employer), which relate to the Company’s proposed business, products or research and development, and which are not assigned to the Company hereunder. If in the course of Employee’s employment with the Company, Employee incorporates into a product, process or machine for the benefit of the Company or any of its wholly owned subsidiaries a Prior Invention owned by Employee or in which the Employee has an interest, the Company is hereby granted and shall have a nonexclusive, royalty-free, irrevocable, perpetual, worldwide license to make, have made, modify, use and sell such Prior Invention as part of or in connection with such product, process or machine.

 

1
 

 

(b) Assignment of Inventions. Employee shall make, or will promptly make, full written disclosure to the Company, will hold in trust for the sole right and benefit of the Company, and hereby assigns to the Company, or its designee, all of Employee’s right, title, and interest in and to any and all inventions, original works of authorship, developments, concepts, improvements, designs, discoveries, ideas, trademarks or trade secrets, whether or not patentable or registerable under copyright or similar laws, which Employee may solely or jointly conceive or develop or reduce to practice, or cause to be conceived or developed or reduced to practice, during the period of time Employee is employed by the Company (collectively referred to as “Inventions”), except as specifically provided in Section 2(f) below. Employee hereby acknowledges that all original works of authorship that are made by Employee (solely or jointly with others) within the scope of and during the period of Employee’s employment with the Company are (i) “works made for hire,” as that term is defined in the United States Copyright Act (to the extent protectable by copyright); and (ii) together with all related intellectual property rights of any sort anywhere in the world, the sole property of the Company. Employee hereby understands and agrees that the decision whether or not to commercialize or market any Inventions developed by Employee solely or jointly with others is within the Company’s sole discretion and for the Company’s sole benefit and that no royalty will be due to Employee as a result of the Company’s efforts to commercialize or market any such Inventions.

 

(c) Inventions Assigned to the United States. Employee shall assign to the United States government all Employee’s right, title, and interest in and to any and all Inventions whenever such full title is required to be in the United States by a contract between the Company and the United States or any of its agencies.

 

(d) Maintenance of Records. Employee shall keep and maintain adequate and current written records of all Inventions made solely or jointly with others during the term of Employee’s employment with the Company. The records will be in the form of notes, sketches, drawings, and any other format that may be specified by the Company. The records will be available to and remain the sole property of the Company at all times.

 

(e) Patent and Copyright Registrations. Employee shall assist the Company, or its designee, at the Company’s expense, in every proper way to secure the Company’s rights in the Inventions and any copyrights, patents, mask work rights or other intellectual property rights relating thereto in any and all countries, including the disclosure to the Company of all pertinent information and data with respect thereto, the execution of all applications, specifications, oaths, assignments and all other instruments which the Company shall deem necessary in order to apply for and obtain such rights and in order to assign and convey to the Company, its successors, assigns, and nominees the sole and exclusive rights, title and interest in and to such Inventions, and any copyrights, patents, mask work rights or other intellectual property rights relating thereto. Employee agrees that it is Employee’s obligation to execute or cause to be executed, when it is in Employee’s power to do so, any such instrument or papers after the termination of this Agreement. If the Company is unable because of the Employee’s mental or physical incapacity or for any other reason to secure Employee’s signature to apply for or to pursue any application for any United States or foreign patents or copyright registrations covering Inventions or original works of authorship assigned to the Company as above, then Employee hereby irrevocably designates and appoints the Company and its duly authorized officers and agents as Employee’s agent and attorney in fact, to act for and in Employee’s behalf and stead to execute and file any such applications and to do all other lawfully permitted acts to further the prosecution and issuance of letters patent or copyright registrations thereon with the same legal force and effect as if executed by Employee.

 

2
 

 

3. Conflicting Employment. Employee shall perform Employee’s duties faithfully and to the best of Employee’s ability and shall devote Employee’s full business time and effort to the performance of Employee’s duties hereunder. Employee shall not, during the term of Employee’s employment with the Company, engage in any other employment, occupation, consulting or other business activity directly related to the business in which the Company, or its subsidiaries are now involved or become involved during the term of Employee’s employment, nor will Employee engage in any other activities that conflict with Employee’s obligations to the Company.

 

4. Returning Company Documents. At the time of leaving the employ of the Company, Employee covenants that Employee shall deliver to the Company (and will not keep in Employee’s possession, recreate or deliver to anyone else) any and all devices, records, data, notes, reports, proposals, lists, correspondence, specifications, drawings, blueprints, sketches, materials, equipment, other documents or property, or reproductions of any aforementioned items developed by Employee pursuant to Employee’s employment with the Company or otherwise belonging to the Company, its successors or assigns, including, without limitation, those records maintained pursuant to paragraph 2(d).

 

5. Notification of New Employer. In the event that Employee leaves the employ of the Company, Employee agrees to grant consent to notification by the Company to Employee’s new employer about Employee’s rights and obligations under this Agreement.

 

6. Solicitation of Employees. Employee covenants that, for a period of twelve (12) months immediately following the termination of Employee’s relationship with the Company for any reason, whether with or without cause, Employee shall not either directly or indirectly solicit, induce, recruit or encourage any of the Company’s employees or employees of any Company subsidiaries to leave their employment, or take away such employees, or attempt to solicit, induce, recruit, encourage or take away their employees, either for Employee or for any other person or entity.

 

7. Right to Advice of Counsel. Employee acknowledges that Employee has had the right to consult with counsel and is fully aware of Employee’s rights and obligations under this Agreement.

 

8. Successors.

 

(a) Company’s Successors. Any successor to the Company (whether direct or indirect and whether by purchase, lease, merger, consolidation, liquidation or otherwise) to all or substantially all of the Company’s business and/or assets shall assume the obligations under this Agreement and agree expressly to perform the obligations under this Agreement in the same manner and to the same extent as the Company would be required to perform such obligations in the absence of a succession. For all purposes under this Agreement, the term “Company,” shall include any successor to the Company’s business and/or assets which executes and delivers the assumption agreement described in this subsection (a) or which becomes bound by the terms of this Agreement by operation of law.

 

3
 

 

(b) Employee’s Successors. Without the written consent of the Company, Employee shall not assign or transfer this Agreement or any right or obligation under this Agreement to any other person or entity. Notwithstanding the foregoing, the terms of this Agreement and all rights of Employee hereunder shall inure to the benefit of, and be enforceable by, Employee’s personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees.

 

9. Notice Clause. Any notice hereby required or permitted to be given shall be sufficiently given if in writing and delivered in person or sent by facsimile, electronic mail, overnight courier or First Class mail, postage prepaid, to either party at the address of such party or such other address as shall have been designated by written notice by such party to the other party. Any notice or other communication required or permitted to be given under this Agreement will be deemed given (i) upon personal delivery to the party to be notified (ii) on the day when delivered by electronic mail to the proper electronic mail address, (iii) when sent by confirmed facsimile if sent during normal business hours of the recipient, if not, then on the next business day, (iv) the first business day after deposit with a nationally recognized overnight courier, specifying next day delivery, or (v) the third business day after the day on which such notice was mailed in accordance with this Section.

 

10. Arbitration.

 

(a) Except as provided in Section 10(e) below, this Agreement shall be governed by the Federal Arbitration Act.

 

(b) The parties may conduct only essential discovery (i.e., discovery sufficient to arbitrate the claim at issue) prior to the hearing, as defined by the AAA arbitrator. Following the hearing, the AAA arbitrator shall issue a written decision, which contains the essential findings and conclusions on which the decision is based. The parties agree that the result of arbitration hereunder shall be final and binding upon the parties, and judgment upon the award may be entered in any court having jurisdiction. The arbitration ruling may be subject to limited judicial review as provided by applicable law.

 

(c) Employee shall bear only those costs of arbitration he or she would otherwise bear had Employee brought a claim covered by this Agreement in court. The Company shall pay for the costs that are unique to the arbitration. Each party will be responsible for payment of its own attorneys’ fees. However, if any party prevails on a statutory claim that affords the prevailing party attorneys’ fees, the arbitrator may award reasonable attorneys’ fees to the prevailing party.

 

(d) The arbitrator shall not have any power, authority or jurisdiction to change or modify any provision of this Agreement.

 

(e) The parties may apply to any court of competent jurisdiction for a temporary restraining order, preliminary injunction, or other interim or a conservatory relief, as necessary, without breach of this arbitration agreement and without abridgement of the powers of the arbitrator.

 

(f) EMPLOYEE HAS READ AND UNDERSTANDS THIS SECTION, WHICH DISCUSSES ARBITRATION. EMPLOYEE UNDERSTANDS THAT BY SIGNING THIS AGREEMENT, EMPLOYEE AGREES TO SUBMIT ANY CLAIMS ARISING OUT OF, RELATING TO, OR IN CONNECTION WITH THIS AGREEMENT, OR THE INTERPRETATION, VALIDITY, CONSTRUCTION, PERFORMANCE, BREACH OR TERMINATION THEREOF TO BINDING ARBITRATION, UNLESS OTHERWISE REQUIRED BY LAW, AND THAT THIS ARBITRATION CLAUSE CONSTITUTES A WAIVER OF EMPLOYEE’S RIGHT TO A JURY TRIAL AND RELATES TO THE RESOLUTION OF ALL DISPUTES RELATING TO EMPLOYEE’S RELATIONSHIP WITH THE COMPANY, INCLUDING, BUT NOT LIMITED TO, CLAIMS OF HARASSMENT, DISCRIMINATION, WRONGFUL TERMINATION AND ANY STATUTORY CLAIMS.

 

4
 

 

11. Severability. The invalidity or unenforceability of any provision of this Agreement, or any terms hereof, shall not affect the validity or enforceability of any other provision or term of this Agreement.

 

12. Integration. This Agreement, together with the offer letter executed on or about the date hereof, represents the entire agreement and understanding between the parties as to the subject matter herein and supersedes all prior or contemporaneous agreements whether written or oral. No waiver, alteration, or modification of any of the provisions of this Agreement shall be binding unless in writing and signed by duly authorized representatives of the parties hereto.

 

13. Governing Law. This Agreement shall be governed by and construed in accordance with the internal substantive laws, but not the choice of law rules, of the state of Nevada.

 

14. Counterparts. This Agreement may be executed in any number of counterparts, each of which shall be an original, and all of which together shall constitute one and the same instrument.

 

IN WITNESS WHEREOF, each of the parties has executed this Agreement, in the case of the Company by their duly authorized officers, as of the day and year first above written.

 

  NEWHYDROGEN, INC.
   
   
  David Lee
  CEO
   
  EMPLOYEE
   
   
  Steven Hill

 

5
 

 

Exhibit A

 

NOT APPLICABLE

 

6
 

 

NewHydrogen, Inc.

 

TERMINATION CERTIFICATION

 

This is to certify that I do not have in my possession, nor have I failed to return, any devices, records, data, notes, reports, proposals, lists, correspondence, specifications, drawings, blueprints, sketches, materials, equipment, other documents or property, or reproductions of any aforementioned items belonging to NewHydrogen, Inc., its subsidiaries, affiliates, successors or assigns (together, the “Company”).

 

I further certify that I have complied with all the terms of the Employee Confidentiality & Inventions Agreement signed by me, including the reporting of any inventions and original works of authorship (as defined therein), conceived or made by me (solely or jointly with others) covered by that agreement.

 

I further agree that, in compliance with the Employee Confidentiality & Inventions Agreement, I will preserve as confidential all trade secrets, confidential knowledge, data or other proprietary information relating to products, processes, know-how, designs, formulas, developmental or experimental work, computer programs, data bases, other original works of authorship, customer lists, business plans, financial information or other subject matter pertaining to any business of the Company or any of its employees, clients, consultants or licensees.

 

I further agree that for twelve (12) months from this date, I will not solicit, induce, recruit or encourage any of the Company’s employees or employees of any Company subsidiaries to leave their employment.

 

  Date:                                  
     
   
   
 

[TO BE SIGNED ONLY UPON TERMINATION OF EMPLOYMENT.]

 

7

 

GRAPHIC 3 ex10-1_001.jpg begin 644 ex10-1_001.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# $! 0$! 0$! 0$! 0$! 0$! 0$! M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_ MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P 1" !, /H# 2( A$! Q$!_\0 M'P 04! 0$! 0$ $" P0%!@<("0H+_\0 M1 @$# P($ P4% M! 0 %] 0(# 01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#^_BBBB@ H MHHH ***^#_V^?VX_"7[%/PMCUM[:Q\2_%;QDM]IOPN\#74\D=M?W]K'$+[Q- MXD-M)%>0>#_#1N[274Q:20WVL7UUIWA_3[FQGU-]6TSV.'\@S?BG.*,BX+X>S;BGB;,:.5Y'DN$J8W,,;6O+DIPM&%*C2A^]Q.+Q5:5+"X/"4(RK MXK%5Z-"E'FG*=+U/]I[]K_X&?LB^$H/$_P 8/%#6U]JGGIX6\#>'XK?5_'WC M*>V0O<1^'?#[W=DIM+;]W%?:_K%[I'AC3+BYL;75-#P9\(OA_P"%_A[X;@$)?3_#6E6] M@VH7$$"6ZZAK5\JMJ.OZO)"BK)6->>8_Z/WA=B=B_&?6;._0RQS?%CX_Z3') M$KD'RI_#GB'XCW6NZ8 '(2TE\/VJ1(IB2*,*L=<_>?\ !*?_ (*,>%G_ +1T M;X837MS'NF-QX2^,G@&TOXB@:0NK7_C/0+J24;<(EH9YY'*K&CL<5_9A16]/ MZ67'>&?LL#PMX?8' )M1R[#Y%BJ6'Y&W:$G0QV$3M'W6UA8QD[R=/5Q.2M]! MGPSQG^T9EQIXJYEFC492S7%\3X*MBG5C%)U(_6,MQTHJ4ES*+QLY03Y8U?=C M)?Q+2_'G_@I/^QOJUFGBCQQ^TA\,T\UM,TS3_BW#KGBWP)J)C#R2VGA^#XEV MGB?P1?AHVE+3^%Y&GC^:2&ZBGA22+]0OV9/^"Y]G>W>G>%_VL? EKH<4SQ6W M_"V?A=9:G>:3:AF@B6Z\5?#NYN-6UVWMXHA<7>HZMX/U3Q!![6# M+1_T):YH6B>)](U'P_XET;2O$.@:Q:RV.K:)KFG6FK:1JEE.-LUGJ.FW\-Q9 M7MK,ORRV]S#+#(.'0BOY^/V\/^"5/P%NIM5\3_LV^-_A_P#!_P"*AT^Y\0/\ M!?%'C70M!\(^-8#-<2_\47%KFHPW?P_U.^E6YLM+@+M\.)[J#3]*6W\$62ZE MK\?U&4>)?@[XNU8Y%XD>'6!X5SG%Q=/#<6<*49TJ5"J^6,:^*KY=EE+,L!2A M.I&52OF>7Y[E,.:^-JX6C*>)C\;GWA!X_> ]"?$WA'XLYCQOP_@9*KB^!N.< M12K5L312E.6'P.'S;.:^4YG7G3HRA2PV3YIPWGE7D4VUU8/.DQT] M=/O8;RV3_2;6\M+FQN(8KN"6%.^AFBN(HKBWECG@GC2:&:%UEBFBE4/'+%(A M9)(Y$971T8JZD,I((-?P5_"_]HOXY?LXZ+\:/A+H&K7VE>%OBAX4^('PR^)O MPW\0I=OI5KJ7B/P]J7@G5/$-GIRW$#Z!X]\/+*!;ZU821M>MIMGIVN1:OI=M M;6T/]C_[!7Q)'Q:_8V_9R\:M<2WE[-\,-!\-:S>3L'FN_$G@!9? /B>[E(5! MON?$/AG4YV 4!3)M!(&3^9^,'@5C?"S 4/I4W.C2Q:Q-*OA5/"UJV#QM%4\9AO8QE.C#]B\!/I+9=XUYI7X?ED= M7A[B'*>%WFV>8"K.I5H1S/#<0QR?%PRNO5C3K5\!+"5L/C'3QF'P^/R[$.K@ M<6J\XTZ\_KFBBBOP _J,**** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@#PGX#_ +3/P+_::T77M?\ @;\0],\>:=X8U:+1/$ M;#7-&U#2;^YLX[^T M%YHWB72]%UF.ROK:1SI^J"P.EZA/9ZG:65Y/=Z3J<%I[M7\1'[#GQS^*7[(? MB^T_:?T73-1UOX'CQEI7P=^..D:7);W$E]IOB&PD\2:8KZ9=201Q:]:06&J: MWX#UA;BUADUC1-4\)ZEJVCZ;XLFAUG^U;PEXL\.>//"WAWQMX/U>S\0>%/%N MB:9XC\.:Y8.SV6K:)K-G#?Z;J%L76.0175I/%,J2QQS1[MDT<-/FHU[_SM]'3QR_XC/PM4JYU@<-DG&F50I8C-\IPU/$4,'C.?A)J5]I/Q"T%/#_BO2G\.ZAINNZEX:O;>2_P!^U&&0V_P!HBDDM)8)Y/?:_G'_8 UC4?#W[67_!6/7](N/L MFK:'J'QDUC2[OR8+C[+J.F?%GXK7ME<>1=136TWDW,$4GDW$,L$FW9+%)&S* M8?V6?&'_ 6+_:X^%%K\7_AM^U7\&-(\-W&N:MX=^Q^./!O@O2M=&HZ&;9;V M5K30/V(EAL//)^'\QA*G&L\=3H1J8>E.%*E2A.K5FIU9> M'PM](K&8S*\AI9GP-Q/Q5Q5Q#FOBA'!97X=97EV)A2R3P]XYQO"DL7BJ>?\ M%.4SA6EAUEM;$RI8JM3J5JU6=.C1@X48?T?5^7'P0_8H\:>,/VGO'_[97[8Z M:!XB^)5EXMOM$_9[^&FEZQ+XL\"_"/X?^%=4O8?!GB*VO;VQTV/5/$DT(UT_P#TG[,'PP_X*8>'O'?B*X_:N_:+^$G MC?X=W_P]\0Z3H%E\.=#T./Q'HGQ"O=2\/MH'B@))\"? -M=6>D:3!XC1[2^U M:_L;B\O+$76B7T:F:SX__@EI^T[\9_CMX7^/?P^_:.\0KXC^-_P'^+4_A?Q) M=IX?\.^&_LNB7UM&-(T32WN;#QAX+^(%LUR-/AN7M8K..YW21;V M\#"Y-GW">1>(>,X4XJX0SO"83+>&8?&9AAL!CL7G?!5 M*MB\5A:>(PN:YGB,%3Q^ RZI0_5.BOR=_P""L?[6WQ5_9E^''PET/X$:_/X= M^+7Q2\=ZHMC>6WA?0_%UTW@CP9H,EQXKBLM*\0Z3KFFF]DUKQ#X*B$SZ9<2Q MV$FH&$POB9/L']BSXWW'[1G[+7P5^+^HW27OB'Q/X-M;3QC=1VUO91W'CKPO M>*]#U>\L;6WBCMXK&XMA;@P&-F^2QO 6?8#@7)?$* MO'"_V#GN<8[)<)"%2H\=3KX&-5K$XFBZ,:5/!8VIAL;0P5:%>I*M6P&+A*G3 M5-.7W.7>)W#.:>)7$/A5AI8S_6?AK(,LXBQTZE&E'+:V&S*=)/"83$1KRK5< MPR^EB\OQ.8T*F'I0H8?,L#.G5K.K)0^H:\RL_C'\-K_XDZC\(;3Q-#-\1=)M MOMFH>&QIVLI-;VW]G:?JWFG4)-.32)!_9^J6%QMAU"1\7 CV^;'+''^?OB7] MH_XT^,/^"IW@S]EWX9>,AI7P=^&WPFE\=_'S08/#GA6^O-2U6YTK4-2TZ!]= MU?0]4UK3;(R>+O@_ 8]&O]'E:'6-4)E,KVTBW?!__*33XE_]BK'_ .JW^'M? MA'C]GW%'@YB? &A0I9%BWXP\?\$Y)F&'Q4<=7Q64\+<79?QGC*-=1I5,##"9 MY5CPQ0QF$YWFʦ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newh-20230311.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 5 newh-20230311_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 6 newh-20230311_pre.xml XBRL PRESENTATION FILE XML 7 R1.htm IDEA: XBRL DOCUMENT v3.22.4
Cover
Mar. 11, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Mar. 11, 2023
Entity File Number 000-54819
Entity Registrant Name NEWHYDROGEN, INC.
Entity Central Index Key 0001371128
Entity Tax Identification Number 20-4754291
Entity Incorporation, State or Country Code NV
Entity Address, Address Line One 27936 Lost Canyon Road
Entity Address, Address Line Two Suite 202
Entity Address, City or Town Santa Clarita
Entity Address, State or Province CA
Entity Address, Postal Zip Code 91387
City Area Code (661)
Local Phone Number 251-0001
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
XML 8 form8-k_htm.xml IDEA: XBRL DOCUMENT 0001371128 2023-03-11 2023-03-11 iso4217:USD shares iso4217:USD shares 0001371128 false 8-K 2023-03-11 NEWHYDROGEN, INC. NV 000-54819 20-4754291 27936 Lost Canyon Road Suite 202 Santa Clarita CA 91387 (661) 251-0001 false false false false false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.4 html 1 20 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://newhydrogen.com/role/Cover Cover Cover 1 false false All Reports Book All Reports form8-k.htm ex10-1.htm newh-20230311.xsd newh-20230311_lab.xml newh-20230311_pre.xml http://xbrl.sec.gov/dei/2022 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form8-k.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 20 }, "contextCount": 1, "dts": { "inline": { "local": [ "form8-k.htm" ] }, "labelLink": { "local": [ "newh-20230311_lab.xml" ] }, "presentationLink": { "local": [ "newh-20230311_pre.xml" ] }, "schema": { "local": [ "newh-20230311.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 59, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 20, "memberCustom": 0, "memberStandard": 0, "nsprefix": "NEWH", "nsuri": "http://newhydrogen.com/20230311", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form8-k.htm", "contextRef": "From2023-03-11to2023-03-11", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://newhydrogen.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form8-k.htm", "contextRef": "From2023-03-11to2023-03-11", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://newhydrogen.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r10": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r11": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r12": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r13": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r14": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r15": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r18": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r19": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r9": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 15 0001493152-23-007923-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-23-007923-xbrl.zip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˸< -M7 5 " :1- M !N97=H+3(P,C,P,S$Q7W!R92YX;6Q02P4& 4 !0 V 0 ,%4 end